Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose

Clinical trial NCT05737342 · RECRUITING

Trial details

NCT number: NCT05737342
Sponsor: SunWay Biotech Co., LTD.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

High Blood Sugar Metabolic Syndrome

Start date: 2023-04-01
Primary completion: 2025-10-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.